Literature DB >> 8216426

Concomitant development of chronic active hepatitis and antibodies to ribosomal P proteins in a patient with systemic lupus erythematosus.

E Koren1, W Schnitz, M Reichlin.   

Abstract

We describe a systemic lupus erythematosus (SLE) patient who for several years had typical SLE features and positive antinuclear antibodies (ANA), including anti-native DNA. Over the course of a year, 4 years after the SLE was diagnosed, the ANA disappeared and antibodies to cytoplasmic component ribosomal P protein (anti-P) appeared. Associated with the appearance of anti-P antibodies was the development of biochemical evidence of liver disease, later shown histologically to be chronic active hepatitis. The temporal relationship between the occurrence of anti-P antibodies and the development of liver disease raises the possibility of a role for anti-P antibodies in liver disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8216426     DOI: 10.1002/art.1780360917

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

Review 1.  Lupus-related hepatitis: complication of lupus or autoimmune association? Case report and review of the literature.

Authors:  Roop Kaw; Carmen Gota; Ana Bennett; David Barnes; Leonard Calabrese
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

2.  Anti-idiotypic antibodies prevent the serologic detection of antiribosomal P autoantibodies in healthy adults.

Authors:  Z J Pan; C J Anderson; H A Stafford
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

3.  Antibodies to ribosomal P proteins and hepatic damage in undifferentiated CTD.

Authors:  J C Torre; L Mozo; A Suárez; E Ramos; C Gutiérrez
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

4.  Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon.

Authors:  Samuel Katsuyuki Shinjo; Eloísa Bonfá
Journal:  Clin Rheumatol       Date:  2010-03-28       Impact factor: 2.980

Review 5.  Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis.

Authors:  Fernando Bessone; Natalia Poles; Marcelo G Roma
Journal:  World J Hepatol       Date:  2014-06-27

6.  Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus.

Authors:  J L J Lin; V Dubljevic; M J Fritzler; Ban-Hock Toh
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

7.  Anti-ribosomal antibodies from lupus patients bind DNA.

Authors:  L Caponi; D Chimenti; F Pratesi; P Migliorini
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

8.  Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus.

Authors:  Fidan Barkhudarova; Cornelia Dähnrich; Anke Rosemann; Udo Schneider; Winfried Stöcker; Gerd-Rüdiger Burmester; Karl Egerer; Wolfgang Schlumberger; Falk Hiepe; Robert Biesen
Journal:  Arthritis Res Ther       Date:  2011-02-10       Impact factor: 5.156

9.  A 17-year-old female with systemic lupus presents with complex movement disorder: possible relationship with antiribosomal p antibodies.

Authors:  Muhammed Emin Ozcan; Meriç Adil Altınöz; Hasan Hüseyin Karadeli; Talip Asil; Abdulkadir Koçer
Journal:  Case Rep Neurol Med       Date:  2013-05-08

Review 10.  Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?

Authors:  Emese Kiss; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.